Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

Total article views   HTML views PDF downloads Totals
10,700 Dovepress* 9,812+ 1,890 11,702
PubMed Central* 888 411 1,299
Totals 10,700 2,301 13,001
*Since 16 April 2018
Total mentioned Facebook Delicious Reddit Twitter Others
24 0 0 0 12 12

View citations on PubMed Central and Google Scholar